marketcaparena
Search

    PODD

    INSULET CORP

    Company overview

    Market capitalization
    $9.23B
    Employees
    5,400
    Latest publication
    2026-09-29
    About INSULET CORP

    Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue801,700,000USD761,700,000USD783,800,000USD706,300,000USD649,100,000USD569,000,000USD597,500,000USD543,900,000USD
    Cost Of Revenue239,100,000USD232,600,000USD215,200,000USD196,200,000USD196,900,000USD160,000,000USD166,600,000USD166,800,000USD
    Gross Profit562,600,000USD529,100,000USD568,600,000USD510,100,000USD452,200,000USD409,000,000USD430,900,000USD377,100,000USD
    Research Development88,100,000USD89,700,000USD90,900,000USD77,200,000USD73,400,000USD59,600,000USD60,600,000USD54,900,000USD
    Selling General Administrative344,800,000USD317,200,000USD331,400,000USD315,200,000USD257,700,000USD241,400,000USD236,800,000USD205,800,000USD
    Total Operating Expenses432,900,000USD406,900,000USD422,300,000USD392,400,000USD331,100,000USD320,200,000USD321,600,000USD289,000,000USD
    Operating Income129,700,000USD122,100,000USD146,300,000USD117,700,000USD121,100,000USD88,800,000USD109,300,000USD88,100,000USD
    Total Other Income Expense Net-11,000,000USD-9,100,000USD-6,100,000USD5,100,000USD-92,700,000USD-40,700,000USD2,000,000USD-5,200,000USD
    Interest Income3,600,000USD4,900,000USD5,700,000USD8,600,000USD10,100,000USD10,300,000USD10,300,000USD10,500,000USD
    Interest Expense13,500,000USD14,700,000USD19,600,000USD15,600,000USD19,600,000USD9,200,000USD8,700,000USD12,300,000USD
    Income Before Tax118,700,000USD113,000,000USD140,200,000USD122,800,000USD28,400,000USD48,100,000USD111,300,000USD82,900,000USD
    Income Tax Expense23,700,000USD21,900,000USD38,500,000USD35,200,000USD5,900,000USD12,700,000USD10,600,000USD5,400,000USD
    Net Income95,000,000USD91,100,000USD101,600,000USD87,600,000USD22,500,000USD35,400,000USD100,700,000USD77,500,000USD
    Net Income Applicable To Common Shares95,000,000USD———————
    Net Interest Income—-9,800,000USD-9,200,000USD-7,000,000USD-9,500,000USD1,100,000USD1,600,000USD-1,800,000USD
    Tax Provision—21,900,000USD38,500,000USD35,200,000USD5,900,000USD12,700,000USD10,600,000USD5,400,000USD
    Net Income From Continuing Ops—91,100,000USD101,600,000USD87,600,000USD22,500,000USD35,400,000USD100,700,000USD77,500,000USD
    Ebit—127,700,000USD159,800,000USD138,400,000USD48,000,000USD57,300,000USD120,000,000USD95,200,000USD
    Ebitda—153,900,000USD190,400,000USD160,400,000USD70,300,000USD79,000,000USD141,500,000USD116,500,000USD
    Depreciation And Amortization—26,200,000USD30,600,000USD22,000,000USD22,300,000USD21,700,000USD21,500,000USD21,300,000USD
    Reconciled Depreciation—26,200,000USD24,400,000USD22,000,000USD22,300,000USD21,700,000USD21,500,000USD21,300,000USD
    Selling And Marketing Expenses—————19,200,000USD24,200,000USD28,300,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue2,708,100,000USD2,071,600,000USD1,697,100,000USD1,305,300,000USD1,098,800,000USD904,400,000USD738,200,000USD563,823,000USD
    Cost Of Revenue768,200,000USD625,900,000USD537,200,000USD499,700,000USD346,700,000USD322,100,000USD257,900,000USD193,655,000USD
    Gross Profit1,939,900,000USD1,445,700,000USD1,159,900,000USD805,600,000USD752,100,000USD582,300,000USD480,300,000USD370,168,000USD
    Research Development301,100,000USD219,600,000USD205,000,000USD180,200,000USD160,100,000USD146,800,000USD132,300,000USD88,606,000USD
    Selling General Administrative1,165,000,000USD832,900,000USD671,800,000USD526,600,000USD466,000,000USD384,000,000USD115,500,000USD111,818,000USD
    Total Operating Expenses1,466,100,000USD1,136,800,000USD939,900,000USD768,000,000USD626,100,000USD530,800,000USD430,300,000USD342,745,000USD
    Operating Income473,800,000USD308,900,000USD220,000,000USD37,600,000USD126,000,000USD51,500,000USD50,000,000USD27,423,000USD
    Interest Income34,700,000USD39,500,000USD28,900,000USD9,800,000USD500,000USD3,000,000USD7,800,000USD6,705,000USD
    Interest Expense79,700,000USD42,700,000USD36,200,000USD36,000,000USD61,700,000USD48,100,000USD34,600,000USD22,197,000USD
    Net Interest Income-24,700,000USD-3,200,000USD-9,800,000USD-26,700,000USD-61,200,000USD-45,100,000USD-26,800,000USD-22,197,000USD
    Income Before Tax339,500,000USD300,200,000USD214,600,000USD9,800,000USD20,500,000USD9,700,000USD14,500,000USD5,226,000USD
    Income Tax Expense92,400,000USD-118,100,000USD8,300,000USD5,200,000USD3,700,000USD2,900,000USD2,900,000USD1,934,000USD
    Tax Provision92,400,000USD-118,100,000USD9,100,000USD5,200,000USD3,700,000USD2,900,000USD2,900,000USD1,934,000USD
    Net Income247,100,000USD418,300,000USD206,300,000USD4,600,000USD16,800,000USD6,800,000USD11,600,000USD3,292,000USD
    Net Income From Continuing Ops247,100,000USD418,300,000USD120,000,000USD4,600,000USD16,800,000USD6,800,000USD11,600,000USD3,292,000USD
    Ebit419,200,000USD342,900,000USD250,800,000USD45,800,000USD82,200,000USD54,900,000USD46,300,000USD27,423,000USD
    Ebitda532,300,000USD423,700,000USD323,600,000USD109,000,000USD139,600,000USD110,300,000USD74,200,000USD43,069,000USD
    Depreciation And Amortization113,100,000USD80,800,000USD72,800,000USD63,200,000USD57,400,000USD55,400,000USD27,900,000USD15,646,000USD
    Reconciled Depreciation90,400,000USD80,800,000USD70,200,000USD63,200,000USD57,400,000USD55,400,000USD27,900,000USD15,646,000USD
    Total Other Income Expense Net-134,300,000USD-8,700,000USD-5,400,000USD-27,800,000USD-105,500,000USD-41,800,000USD-35,500,000USD-22,197,000USD
    Selling And Marketing Expenses—84,300,000USD63,100,000USD41,200,000USD——185,100,000USD142,321,000USD
    Unclassified Operating Expenses———20,000,000USD————
    Non Operating Income Net Other———-1,100,000USD-44,300,000USD3,300,000USD-900,000USD6,705,000USD
    Net Income Applicable To Common Shares———4,600,000USD16,800,000USD6,800,000USD11,600,000USD3,292,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets3,165,100,000USD2,987,200,000USD3,190,400,000USD3,029,300,000USD3,469,200,000USD3,517,300,000USD3,087,700,000USD3,025,400,000USD
    Total Current Assets1,849,100,000USD1,709,500,000USD1,888,700,000USD1,859,400,000USD2,257,100,000USD2,307,000,000USD1,871,200,000USD1,841,600,000USD
    Other Current Assets240,700,000USD221,900,000USD203,100,000USD193,500,000USD244,100,000USD180,800,000USD121,900,000USD118,500,000USD
    Other Non Current Assets290,800,000USD———————
    Total Liabilities1,742,900,000USD———————
    Total Current Liabilities744,200,000USD687,500,000USD680,100,000USD647,700,000USD1,010,100,000USD520,400,000USD528,400,000USD506,200,000USD
    Other Current Liabilities602,000,000USD———————
    Other Non Current Liabilities69,200,000USD———————
    Total Stockholder Equity1,422,200,000USD1,302,600,000USD1,515,200,000USD1,384,100,000USD1,462,900,000USD1,330,700,000USD1,211,600,000USD1,118,000,000USD
    Total Equity Including Noncontrolling Interest1,422,200,000USD———————
    Short Long Term Debt18,900,000USD18,600,000USD18,400,000USD79,900,000USD460,700,000USD83,100,000USD96,000,000USD42,000,000USD
    Long Term Debt929,500,000USD929,500,000USD930,800,000USD934,900,000USD939,000,000USD1,612,300,000USD1,296,100,000USD1,356,300,000USD
    Deferred Revenue12,400,000USD———————
    Deferred Revenue Non Current2,100,000USD———————
    Net Receivables588,700,000USD544,700,000USD516,900,000USD462,200,000USD444,500,000USD402,300,000USD365,500,000USD375,600,000USD
    Inventory484,800,000USD462,500,000USD452,600,000USD446,300,000USD446,900,000USD440,800,000USD430,400,000USD444,900,000USD
    Property Plant Equipment Net858,600,000USD830,400,000USD863,200,000USD724,100,000USD720,400,000USD718,700,000USD759,800,000USD702,900,000USD
    Goodwill51,600,000USD———————
    Accounts Payable123,300,000USD149,800,000USD75,000,000USD48,200,000USD96,100,000USD57,600,000USD19,800,000USD40,300,000USD
    Common Stock100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD
    Retained Earnings473,500,000USD378,500,000USD287,400,000USD185,800,000USD98,200,000USD75,700,000USD40,300,000USD-60,400,000USD
    Accumulated Other Comprehensive Income1,900,000USD5,600,000USD13,200,000USD13,100,000USD16,300,000USD-6,000,000USD-13,200,000USD19,700,000USD
    Cash And Equivalents534,900,000USD———————
    Intangible Assets—115,200,000USD117,100,000USD105,000,000USD102,300,000USD99,800,000USD98,500,000USD99,600,000USD
    Total Liab—1,684,600,000USD1,675,200,000USD1,645,200,000USD2,006,200,000USD2,186,600,000USD1,876,100,000USD1,907,400,000USD
    Other Current Liab—519,100,000USD568,900,000USD486,600,000USD418,200,000USD364,300,000USD410,700,000USD401,100,000USD
    Capital Stock—100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD
    Good Will—51,600,000USD51,600,000USD51,600,000USD51,700,000USD51,500,000USD51,500,000USD51,700,000USD
    Cash—480,400,000USD716,100,000USD757,400,000USD992,900,000USD1,283,100,000USD953,400,000USD902,600,000USD
    Cash And Short Term Investments—480,400,000USD716,100,000USD757,400,000USD1,121,600,000USD1,283,100,000USD953,400,000USD902,600,000USD
    Net Debt—467,700,000USD334,700,000USD273,900,000USD424,500,000USD412,300,000USD468,600,000USD495,700,000USD
    Short Term Debt—18,600,000USD22,200,000USD96,400,000USD478,400,000USD83,100,000USD85,900,000USD42,000,000USD
    Short Long Term Debt Total—948,100,000USD1,050,800,000USD1,031,300,000USD1,417,400,000USD1,695,400,000USD1,422,000,000USD1,398,300,000USD
    Common Stock Shares Outstanding—70,202,000shares70,667,000shares70,661,000shares70,641,000shares74,111,000shares74,079,000shares73,951,000shares
    Non Current Assets Total—1,277,700,000USD1,301,700,000USD1,169,900,000USD1,212,100,000USD1,210,300,000USD1,216,499,999USD1,183,800,000USD
    Non Current Liabilities Total—997,100,000USD995,100,000USD997,500,000USD996,100,000USD1,666,199,999USD1,347,699,999USD1,401,200,000USD
    Non Current Liabilities Other—67,600,000USD64,200,000USD62,400,000USD57,800,000USD53,900,000USD51,600,000USD44,900,000USD
    Non Currrent Assets Other—261,400,000USD167,300,000USD169,200,000USD318,600,000USD338,900,000USD164,899,999USD185,200,000USD
    Net Working Capital—1,022,000,000USD1,233,900,000USD1,211,700,000USD1,269,600,000USD1,808,000,000USD1,362,900,000USD1,354,700,000USD
    Unclassified Non Current Assets—19,100,000USD102,500,000USD120,000,000USD19,100,000USD—141,800,000USD144,400,000USD
    Unclassified Current Liabilities—-18,600,000USD-18,400,000USD-79,900,000USD-460,700,000USD-83,100,000USD-96,000,000USD-42,000,000USD
    Unclassified Equity—918,300,000USD1,214,400,000USD1,185,000,000USD1,348,200,000USD1,260,800,000USD1,184,300,000USD1,158,500,000USD
    Current Deferred Revenue——14,000,000USD16,500,000USD17,400,000USD15,400,000USD12,000,000USD22,800,000USD
    Property Plant Equipment Gross——1,252,200,000USD———1,085,500,000USD—
    Short Term Investments————128,699,999USD———
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets3,190,400,000USD3,087,700,000USD2,588,200,000USD2,251,100,000USD2,048,800,000USD1,872,900,000USD1,142,900,000USD928,744,000USD
    Intangible Assets117,100,000USD98,500,000USD98,700,000USD75,500,000USD36,600,000USD28,700,000USD13,200,000USD10,383,000USD
    Other Current Assets203,100,000USD121,900,000USD99,800,000USD71,700,000USD74,000,000USD63,000,000USD31,100,000USD16,977,000USD
    Total Liab1,675,200,000USD1,876,100,000USD1,855,500,000USD1,774,700,000USD1,492,500,000USD1,269,300,000USD1,067,000,000USD716,645,000USD
    Total Stockholder Equity1,515,200,000USD1,211,600,000USD732,700,000USD476,400,000USD556,300,000USD603,600,000USD75,900,000USD212,099,000USD
    Other Current Liab568,900,000USD410,700,000USD363,700,000USD286,700,000USD162,500,000USD132,700,000USD96,400,000USD80,510,000USD
    Common Stock100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD59,000USD
    Capital Stock100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD59,000USD
    Retained Earnings287,400,000USD40,300,000USD-378,000,000USD-584,300,000USD-649,500,000USD-666,300,000USD-672,000,000USD-683,614,000USD
    Good Will51,600,000USD51,500,000USD51,700,000USD51,700,000USD39,800,000USD39,800,000USD39,800,000USD39,646,000USD
    Cash716,100,000USD953,400,000USD650,700,000USD623,900,000USD791,600,000USD947,600,000USD376,100,000USD113,906,000USD
    Cash And Short Term Investments716,100,000USD953,400,000USD704,200,000USD674,700,000USD791,600,000USD947,600,000USD376,100,000USD288,946,000USD
    Total Current Assets1,888,700,000USD1,871,200,000USD1,566,300,000USD1,298,800,000USD1,329,800,000USD1,248,700,000USD591,000,000USD454,009,000USD
    Total Current Liabilities680,100,000USD528,400,000USD451,200,000USD364,700,000USD228,800,000USD207,800,000USD157,700,000USD115,657,000USD
    Current Deferred Revenue14,000,000USD12,000,000USD15,400,000USD16,100,000USD3,500,000USD5,400,000USD3,200,000USD1,184,000USD
    Net Debt334,700,000USD468,600,000USD798,100,000USD808,900,000USD457,200,000USD96,100,000USD511,800,000USD478,072,000USD
    Short Term Debt22,200,000USD85,900,000USD52,900,000USD31,100,000USD25,100,000USD15,600,000USD3,600,000USD—
    Short Long Term Debt18,400,000USD96,000,000USD49,400,000USD27,500,000USD25,100,000USD15,600,000USD——
    Short Long Term Debt Total1,050,800,000USD1,422,000,000USD1,448,800,000USD1,432,800,000USD1,273,900,000USD1,059,300,000USD891,500,000USD591,978,000USD
    Long Term Debt930,800,000USD1,296,100,000USD1,366,400,000USD1,374,300,000USD1,248,800,000USD1,043,700,000USD887,900,000USD591,978,000USD
    Net Receivables516,900,000USD365,500,000USD359,700,000USD205,600,000USD161,000,000USD83,800,000USD82,800,000USD76,672,000USD
    Inventory452,600,000USD430,400,000USD402,600,000USD346,800,000USD303,200,000USD154,300,000USD101,000,000USD71,414,000USD
    Accounts Payable75,000,000USD19,800,000USD19,200,000USD30,800,000USD37,700,000USD54,100,000USD54,500,000USD25,500,000USD
    Property Plant Equipment Net863,200,000USD759,800,000USD692,800,000USD625,900,000USD536,500,000USD478,700,000USD399,400,000USD258,379,000USD
    Property Plant Equipment Gross1,252,200,000USD1,085,500,000USD958,100,000USD834,600,000USD715,700,000USD478,700,000USD399,400,000USD258,379,000USD
    Accumulated Other Comprehensive Income13,200,000USD-13,200,000USD8,000,000USD20,000,000USD-2,200,000USD5,500,000USD-1,200,000USD-2,905,000USD
    Common Stock Shares Outstanding71,886,000shares73,890,000shares73,633,000shares69,910,000shares68,579,000shares65,946,000shares62,304,348shares61,008,000shares
    Non Current Assets Total1,301,700,000USD1,216,499,999USD1,021,899,999USD952,300,000USD719,000,000USD624,200,000USD551,900,000USD474,735,000USD
    Non Current Liabilities Total995,100,000USD1,347,699,999USD1,404,300,000USD1,410,000,000USD1,263,700,000USD1,061,500,000USD909,300,000USD600,988,000USD
    Non Current Liabilities Other64,200,000USD51,600,000USD37,900,000USD35,700,000USD14,900,000USD17,800,000USD21,400,000USD9,010,000USD
    Non Currrent Assets Other167,300,000USD159,399,999USD178,699,999USD184,200,000USD106,100,000USD77,000,000USD41,100,000USD25,542,999USD
    Net Working Capital1,233,900,000USD1,362,900,000USD1,131,700,000USD949,300,000USD1,101,000,000USD1,040,900,000USD433,300,000USD345,629,000USD
    Unclassified Non Current Assets102,500,000USD147,300,000USD—-132,100,000USD-106,100,000USD-79,000,000USD-25,000,000USD-18,199,999USD
    Unclassified Current Liabilities-18,400,000USD-96,000,000USD-49,400,000USD-27,500,000USD-25,100,000USD-15,600,000USD—8,463,000USD
    Unclassified Equity1,214,400,000USD1,184,300,000USD1,102,500,000USD1,040,500,000USD1,207,800,000USD1,264,200,000USD748,900,000USD898,500,000USD
    Other Assets——1USD147,100,000USD106,100,000USD79,000,000USD25,000,000USD18,200,000USD
    Short Term Investments——53,500,000USD50,800,000USD0USD40,400,000USD162,400,000USD175,040,000USD
    Deferred Long Term Liab———31,300,000USD26,100,000USD21,900,000USD19,900,000USD16,000,000USD
    Other Liab———8,300,000USD14,900,000USD17,800,000USD7,000,000USD8,900,000USD
    Net Tangible Assets———349,200,000USD479,900,000USD535,100,000USD22,900,000USD162,070,000USD
    Unclassified Non Current Liabilities———-39,600,000USD-41,000,000USD-39,700,000USD-26,900,000USD-24,900,000USD
    Long Term Investments—————0USD58,400,000USD140,784,000USD
    Unclassified Current Assets—————-40,400,000USD-162,400,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation52,900,000USD
    Stock Based Compensation40,900,000USD
    Deferred Income Tax15,200,000USD
    Other Non Cash Items0USD
    Change To Inventory-34,900,000USD
    Change To Liabilities45,500,000USD
    Change In Working Capital-23,100,000USD
    Operating Cash Flow202,200,000USD
    Capital Expenditures-56,800,000USD
    Unclassified Investing Cash Flow-8,300,000USD
    Investing Cash Flow-65,100,000USD
    Net Common Stock Issuance-316,200,000USD
    Unclassified Financing Cash Flow300,000USD
    Financing Cash Flow-315,900,000USD
    Effect Of Forex Changes On Cash-2,400,000USD
    Change In Cash-181,200,000USD
    End Cash Flow534,900,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income91,100,000USD101,600,000USD87,600,000USD22,500,000USD35,400,000USD100,700,000USD77,500,000USD188,600,000USD
    Depreciation26,200,000USD24,400,000USD22,000,000USD22,300,000USD21,700,000USD21,500,000USD21,300,000USD19,200,000USD
    Stock Based Compensation21,300,000USD20,300,000USD16,700,000USD7,500,000USD18,200,000USD20,000,000USD18,100,000USD17,000,000USD
    Other Non Cash Items600,000USD3,000,000USD-10,200,000USD91,100,000USD53,500,000USD900,000USD-3,700,000USD-133,600,000USD
    Change To Account Receivables-30,600,000USD-54,100,000USD23,500,000USD-33,500,000USD-33,400,000USD4,500,000USD-5,700,000USD-45,800,000USD
    Change To Inventory-11,500,000USD-5,900,000USD-22,500,000USD1,900,000USD-6,600,000USD6,200,000USD-8,300,000USD-700,000USD
    Change In Working Capital-32,400,000USD14,500,000USD-33,100,000USD53,100,000USD-65,000,000USD700,000USD-13,100,000USD-4,400,000USD
    Total Cash From Operating Activities113,800,000USD183,300,000USD125,700,000USD196,500,000USD63,800,000USD147,700,000USD98,500,000USD86,800,000USD
    Capital Expenditures-27,800,000USD-135,100,000USD-21,000,000USD-23,200,000USD-12,300,000USD-56,000,000USD-26,700,000USD-22,500,000USD
    Free Cash Flow86,000,000USD48,200,000USD104,700,000USD173,300,000USD51,500,000USD91,700,000USD71,800,000USD64,300,000USD
    Total Cashflows From Investing Activities-27,700,000USD-152,800,000USD-31,000,000USD-23,200,000USD-15,700,000USD-68,000,000USD-29,300,000USD-24,900,000USD
    Net Borrowings-4,500,000USD-81,300,000USD-518,700,000USD-381,500,000USD273,400,000USD-26,700,000USD-1,900,000USD—
    Total Cash From Financing Activities-319,900,000USD-72,500,000USD-456,999,999USD-343,600,000USD277,800,000USD-20,900,000USD7,800,000USD8,800,000USD
    Sale Purchase Of Stock-300,000,000USD0USD-29,500,000USD-30,100,000USD0USD—11,000,000USD-1,100,000USD
    Change In Cash-235,700,000USD-41,300,000USD-364,200,000USD-161,500,000USD329,700,000USD50,800,000USD81,600,000USD69,800,000USD
    Begin Period Cash Flow716,100,000USD757,400,000USD1,121,600,000USD1,283,100,000USD953,400,000USD902,600,000USD821,000,000USD751,200,000USD
    End Period Cash Flow480,400,000USD716,100,000USD757,400,000USD1,121,600,000USD1,283,100,000USD953,400,000USD902,600,000USD821,000,000USD
    Other Cashflows From Investing Activities100,000USD-3,400,000USD-13,400,000USD—-3,400,000USD—-6,700,000USD—
    Other Cashflows From Financing Activities-15,800,000USD-800,000USD91,200,000USD73,900,000USD-21,200,000USD-600,000USD-900,000USD8,600,000USD
    Unclassified Operating Cash Flow7,000,000USD19,500,000USD42,700,000USD——3,900,000USD-1,600,000USD—
    Investments—0USD-31,000,000USD-23,200,000USD-15,700,000USD-68,000,000USD-29,300,000USD-24,900,000USD
    Unclassified Investing Cash Flow—-14,300,000USD34,400,000USD23,200,000USD15,700,000USD56,000,000USD33,400,000USD22,500,000USD
    Unclassified Financing Cash Flow—9,600,000USD—-5,900,000USD25,600,000USD6,400,000USD—1,300,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income247,100,000USD418,300,000USD206,300,000USD4,600,000USD16,800,000USD6,800,000USD11,600,000USD3,300,000USD
    Depreciation90,400,000USD80,800,000USD72,800,000USD63,200,000USD57,400,000USD55,400,000USD27,900,000USD15,600,000USD
    Stock Based Compensation62,700,000USD69,300,000USD48,300,000USD40,900,000USD34,400,000USD35,900,000USD28,700,000USD37,500,000USD
    Other Non Cash Items130,000,000USD15,800,000USD8,400,000USD13,800,000USD86,900,000USD49,300,000USD49,900,000USD32,300,000USD
    Change To Account Receivables-140,200,000USD-10,400,000USD-154,200,000USD-51,800,000USD-71,300,000USD-13,700,000USD-10,900,000USD-14,600,000USD
    Change To Inventory-10,600,000USD-32,400,000USD-53,600,000USD-49,100,000USD-154,400,000USD-50,500,000USD-30,200,000USD-38,800,000USD
    Change In Working Capital-23,100,000USD-17,000,000USD-190,600,000USD-2,500,000USD-263,600,000USD-63,400,000USD-19,700,000USD-52,800,000USD
    Total Cash From Operating Activities569,300,000USD430,300,000USD145,700,000USD119,000,000USD-68,100,000USD84,000,000USD98,400,000USD35,900,000USD
    Capital Expenditures-191,600,000USD-124,900,000USD-75,600,000USD-157,300,000USD-122,700,000USD-166,500,000USD-170,900,000USD-162,354,000USD
    Free Cash Flow377,700,000USD305,400,000USD70,100,000USD-38,300,000USD-190,800,000USD-82,500,000USD-72,500,000USD-126,455,000USD
    Investments0USD-146,200,000USD-176,200,000USD-7,800,000USD40,000,000USD180,500,000USD97,300,000USD-22,150,000USD
    Total Cashflows From Investing Activities-222,700,000USD-146,200,000USD-119,400,000USD-191,100,000USD-82,700,000USD14,000,000USD-73,600,000USD-184,500,000USD
    Net Borrowings-708,100,000USD-40,600,000USD-27,000,000USD-39,800,000USD-464,900,000USD128,300,000USD31,200,000USD-6,699,000USD
    Total Cash From Financing Activities-595,300,000USD-28,100,000USD-13,600,000USD-40,300,000USD40,700,000USD605,500,000USD73,500,000USD-8,700,000USD
    Sale Purchase Of Stock-59,600,000USD11,900,000USD10,600,000USD-16,800,000USD-28,200,000USD-29,800,000USD-8,600,000USD-17,800,000USD
    Change In Cash-237,300,000USD249,200,000USD14,500,000USD-116,700,000USD-115,600,000USD708,300,000USD99,800,000USD-158,700,000USD
    Begin Period Cash Flow953,400,000USD704,200,000USD689,700,000USD806,400,000USD922,000,000USD213,700,000USD113,900,000USD272,600,000USD
    End Period Cash Flow716,100,000USD953,400,000USD704,200,000USD689,700,000USD806,400,000USD922,000,000USD213,700,000USD113,900,000USD
    Other Cashflows From Investing Activities-31,100,000USD-21,300,000USD-33,600,000USD-40,000,000USD29,200,000USD-166,500,000USD-170,900,000USD-46,000USD
    Other Cashflows From Financing Activities138,500,000USD-7,600,000USD-13,500,000USD-16,800,000USD-32,200,000USD-30,300,000USD-8,600,000USD-17,815,000USD
    Unclassified Operating Cash Flow62,200,000USD-136,900,000USD——————
    Unclassified Financing Cash Flow33,900,000USD8,200,000USD26,900,000USD33,100,000USD589,500,000USD635,800,000USD68,100,000USD33,614,000USD
    Unclassified Investing Cash Flow—146,200,000USD166,000,000USD14,000,000USD-29,200,000USD166,500,000USD170,900,000USD—
    Dividends Paid——-10,600,000USD—-23,500,000USD-98,500,000USD-8,600,000USD—
    Change To Liabilities———131,500,000USD8,800,000USD34,900,000USD41,300,000USD24,270,000USD
    Issuance Of Capital Stock———0USD0USD477,500,000USD50,900,000USD15,815,000USD
    Cash And Cash Equivalents Changes———-112,400,000USD-110,100,000USD703,500,000USD98,300,000USD-158,671,000USD
    Exchange Rate Changes———————-1,401,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyInternational251,800,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States549,900,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductDrug Delivery5,800,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductInternational Omnipod251,800,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductProduct Omnipod — U.S.Omnipod544,100,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational242,900,000USD0001145197-26-000102
    Q1 2026Quarterly · 2026-03-31GeographyUnited States518,800,000USD0001145197-26-000102
    Q4 2025Quarterly · 2025-12-31GeographyInternational214,100,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States569,800,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductDrug Delivery1,900,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductInternational Omnipod214,100,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProduct Omnipod — U.S.Omnipod567,800,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyInternational754,300,000USD0001145197-26-000028
    FY 2025Yearly · 2025-12-31GeographyUnited States1,953,900,000USD0001145197-26-000028
    FY 2025Yearly · 2025-12-31ProductDrug Delivery34,100,000USD0001145197-26-000028
    FY 2025Yearly · 2025-12-31ProductInternational Omnipod754,300,000USD0001145197-26-000028
    FY 2025Yearly · 2025-12-31ProductProduct Omnipod — U.S.Omnipod1,919,800,000USD0001145197-26-000028
    Q3 2025Quarterly · 2025-09-30GeographyInternational202,100,000USD0001145197-25-000069
    Q3 2025Quarterly · 2025-09-30GeographyUnited States504,200,000USD0001145197-25-000069
    Q3 2025Quarterly · 2025-09-30ProductDrug Delivery7,100,000USD0001145197-25-000069
    Q3 2025Quarterly · 2025-09-30ProductInternational Omnipod202,100,000USD0001145197-25-000069
    Q3 2025Quarterly · 2025-09-30ProductProduct Omnipod — U.S.Omnipod497,100,000USD0001145197-25-000069
    Q2 2025Quarterly · 2025-06-30GeographyInternational185,800,000USD0001145197-25-000038
    Q2 2025Quarterly · 2025-06-30GeographyUnited States463,300,000USD0001145197-25-000038
    Q2 2025Quarterly · 2025-06-30ProductDrug Delivery10,200,000USD0001145197-25-000038
    Q2 2025Quarterly · 2025-06-30ProductInternational Omnipod185,800,000USD0001145197-25-000038
    Q2 2025Quarterly · 2025-06-30ProductProduct Omnipod — U.S.Omnipod453,200,000USD0001145197-25-000038
    Q1 2025Quarterly · 2025-03-31GeographyInternational152,300,000USD0001145197-26-000102
    Q1 2025Quarterly · 2025-03-31GeographyUnited States416,600,000USD0001145197-26-000102
    Q1 2025Quarterly · 2025-03-31ProductDrug Delivery14,900,000USD0001145197-26-000102
    Q1 2025Quarterly · 2025-03-31ProductInternational Omnipod152,300,000USD0001145197-26-000102
    Q1 2025Quarterly · 2025-03-31ProductProduct Omnipod — U.S.Omnipod401,700,000USD0001145197-26-000102
    Q4 2024Quarterly · 2024-12-31GeographyInternational142,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States455,500,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductDrug Delivery11,800,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductInternational Omnipod142,100,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProduct Omnipod — U.S.Omnipod443,700,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational523,400,000USD0001145197-26-000028
    FY 2024Yearly · 2024-12-31GeographyUnited States1,548,200,000USD0001145197-26-000028
    FY 2024Yearly · 2024-12-31ProductDrug Delivery38,900,000USD0001145197-26-000028
    FY 2024Yearly · 2024-12-31ProductInternational Omnipod523,400,000USD0001145197-26-000028
    FY 2024Yearly · 2024-12-31ProductProduct Omnipod — U.S.Omnipod1,509,300,000USD0001145197-26-000028
    Q3 2024Quarterly · 2024-09-30GeographyInternational137,900,000USD0001145197-25-000069
    Q3 2024Quarterly · 2024-09-30GeographyUnited States406,000,000USD0001145197-25-000069
    Q3 2024Quarterly · 2024-09-30ProductDrug Delivery10,300,000USD0001145197-25-000069
    Q3 2024Quarterly · 2024-09-30ProductInternational Omnipod137,900,000USD0001145197-25-000069
    Q3 2024Quarterly · 2024-09-30ProductProduct Omnipod — U.S.Omnipod395,600,000USD0001145197-25-000069
    Q2 2024Quarterly · 2024-06-30ProductDrug Delivery8,100,000USD0001145197-24-000039
    Q2 2024Quarterly · 2024-06-30ProductInternational Omnipod128,100,000USD0001145197-24-000039
    Q2 2024Quarterly · 2024-06-30ProductProduct Omnipod — U.S.Omnipod352,300,000USD0001145197-24-000039
    FY 2023Yearly · 2023-12-31GeographyInternational410,100,000USD0001145197-26-000028
    FY 2023Yearly · 2023-12-31GeographyUnited States1,287,000,000USD0001145197-26-000028
    FY 2023Yearly · 2023-12-31ProductDrug Delivery36,000,000USD0001145197-26-000028
    FY 2023Yearly · 2023-12-31ProductInternational Omnipod410,100,000USD0001145197-26-000028
    FY 2023Yearly · 2023-12-31ProductProduct Omnipod — U.S.Omnipod1,251,000,000USD0001145197-26-000028
    FY 2022Yearly · 2022-12-31GeographyInternational363,000,000USD0001145197-25-000007
    FY 2022Yearly · 2022-12-31GeographyUnited States942,300,000USD0001145197-25-000007
    FY 2022Yearly · 2022-12-31ProductDrug Delivery57,500,000USD0001145197-25-000007
    FY 2022Yearly · 2022-12-31ProductInternational Omnipod363,000,000USD0001145197-25-000007
    FY 2022Yearly · 2022-12-31ProductProduct Omnipod — U.S.Omnipod884,800,000USD0001145197-25-000007
    FY 2021Yearly · 2021-12-31GeographyInternational359,900,000USD0001145197-24-000011
    FY 2021Yearly · 2021-12-31GeographyUnited States738,900,000USD0001145197-24-000011
    FY 2021Yearly · 2021-12-31ProductDrug Delivery87,400,000USD0001145197-24-000011
    FY 2021Yearly · 2021-12-31ProductInternational Omnipod359,900,000USD0001145197-24-000011
    FY 2021Yearly · 2021-12-31ProductProduct Omnipod — U.S.Omnipod651,500,000USD0001145197-24-000011
    FY 2020Yearly · 2020-12-31GeographyInternational308,000,000USD0001145197-23-000020
    FY 2020Yearly · 2020-12-31GeographyUnited States596,400,000USD0001145197-23-000020
    FY 2020Yearly · 2020-12-31ProductDrug Delivery69,500,000USD0001145197-23-000020
    FY 2020Yearly · 2020-12-31ProductInternational Omnipod308,000,000USD0001145197-23-000020
    FY 2020Yearly · 2020-12-31ProductProduct Omnipod — U.S.Omnipod526,900,000USD0001145197-23-000020
    FY 2019Yearly · 2019-12-31GeographyInternational253,100,000USD0001145197-22-000012
    FY 2019Yearly · 2019-12-31GeographyUnited States485,100,000USD0001145197-22-000012
    FY 2019Yearly · 2019-12-31ProductDrug Delivery64,700,000USD0001145197-22-000012
    FY 2019Yearly · 2019-12-31ProductInternational Omnipod253,100,000USD0001145197-22-000012
    FY 2019Yearly · 2019-12-31ProductProduct Omnipod — U.S.Omnipod420,400,000USD0001145197-22-000012
    FY 2018Yearly · 2018-12-31GeographyInternational172,000,000USD0001145197-21-000009
    FY 2018Yearly · 2018-12-31GeographyUnited States391,800,000USD0001145197-21-000009
    FY 2018Yearly · 2018-12-31ProductDrug Delivery68,300,000USD0001145197-21-000009
    FY 2018Yearly · 2018-12-31ProductInternational Omnipod172,000,000USD0001145197-21-000009
    FY 2018Yearly · 2018-12-31ProductProduct Omnipod — U.S.Omnipod323,500,000USD0001145197-21-000009

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.